# Replimune Posts 54-Cent Q2 GAAP Loss, Beats Estimate by 21 Cents

By John Kim

Canonical URL: https://www.tokenpost.com/news/business/42627
Published: 2026-10-28T13:39:53.000Z
Updated: 2026-10-28T13:39:53.000Z
Section: Business

> Cash and cash equivalents totaled $307.8 million on Sept. 30, 2026; the March 31 balance included short-term investments.

Replimune Group, Inc. posted a second-quarter GAAP loss of 54 cents per share, beating the estimate by 21 cents.

Cash and cash equivalents totaled $307.8 million as of Sept. 30, 2026. As of March 31, 2026, the company had $268.9 million in cash, cash equivalents and short-term investments. The reported totals cover different asset categories.